JP2022549892A5 - - Google Patents
Info
- Publication number
- JP2022549892A5 JP2022549892A5 JP2022519283A JP2022519283A JP2022549892A5 JP 2022549892 A5 JP2022549892 A5 JP 2022549892A5 JP 2022519283 A JP2022519283 A JP 2022519283A JP 2022519283 A JP2022519283 A JP 2022519283A JP 2022549892 A5 JP2022549892 A5 JP 2022549892A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- aav vector
- vector according
- seq
- pgrn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201913974A GB201913974D0 (en) | 2019-09-27 | 2019-09-27 | Vector |
| GB1913974.0 | 2019-09-27 | ||
| PCT/EP2020/077144 WO2021058830A1 (en) | 2019-09-27 | 2020-09-28 | Vector |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066254A Division JP2026133380A (ja) | 2019-09-27 | 2026-04-14 | ベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022549892A JP2022549892A (ja) | 2022-11-29 |
| JP2022549892A5 true JP2022549892A5 (cg-RX-API-DMAC7.html) | 2023-10-12 |
| JP7854715B2 JP7854715B2 (ja) | 2026-05-07 |
Family
ID=68538788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519283A Active JP7854715B2 (ja) | 2019-09-27 | 2020-09-28 | ベクター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12680109B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4034664A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7854715B2 (cg-RX-API-DMAC7.html) |
| CN (3) | CN119913208A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020354538A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3155742A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201913974D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021058830A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201913974D0 (en) | 2019-09-27 | 2019-11-13 | King S College London | Vector |
| EP4384195A2 (en) * | 2021-08-11 | 2024-06-19 | King's College London | Compositions and methods for improved treatment of disorders affecting the central nervous system |
| CN116064624A (zh) * | 2022-09-15 | 2023-05-05 | 思鹏生物科技(苏州)有限公司 | 利用rpl基因促进载体稳定表达的方法及其功能基因 |
| WO2024245120A1 (en) * | 2023-05-26 | 2024-12-05 | Shanghai Vitalgen Biopharma Co., Ltd. | Recombinant aav vectors for treating proteinopathies in central nervous system |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| AU4645697A (en) | 1996-09-11 | 1998-04-02 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Aav4 vector and uses thereof |
| US6083725A (en) * | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| DE69939169D1 (de) | 1998-05-28 | 2008-09-04 | Us Gov Health & Human Serv | Aav5 vektoren und deren verwendung |
| DE69936104T2 (de) | 1998-11-05 | 2008-01-17 | The Trustees Of The University Of Pennsylvania | Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten |
| US7071172B2 (en) * | 2002-04-30 | 2006-07-04 | The University Of North Carolina At Chapel Hill | Secretion signal vectors |
| JP5123936B2 (ja) | 2006-05-30 | 2013-01-23 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 認知症の検出および治療 |
| US20130090374A1 (en) | 2011-04-20 | 2013-04-11 | Miguel Sena-Esteves | Methods for the treatment of tay-sachs disease, sandhoff disease, and gm1-gangliosidosis |
| DK3693025T3 (da) | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| SG10201707569YA (en) * | 2012-12-12 | 2017-10-30 | Broad Inst Inc | Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications |
| JP6738728B2 (ja) * | 2013-06-17 | 2020-08-19 | ザ・ブロード・インスティテュート・インコーポレイテッド | 肝臓ターゲティングおよび治療のためのCRISPR−Cas系、ベクターおよび組成物の送達および使用 |
| EP3632923A1 (en) * | 2015-01-16 | 2020-04-08 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| AU2016366549B2 (en) * | 2015-12-11 | 2022-11-10 | California Institute Of Technology | Targeting peptides for directing adeno-associated viruses (AAVs) |
| CA3016314A1 (en) | 2016-03-02 | 2017-09-08 | Julianne REIDERS | Therapy for frontotemporal dementia |
| EP3692158A4 (en) * | 2017-10-03 | 2021-08-04 | Prevail Therapeutics, Inc. | GENE THERAPIES FOR LYSOSOMAL DISEASES |
| CN118345115A (zh) | 2017-12-01 | 2024-07-16 | 编码治疗公司 | 工程化的dna结合蛋白 |
| KR102171360B1 (ko) * | 2018-06-22 | 2020-10-28 | 재단법인대구경북과학기술원 | 사이토카인 융합 폴리펩티드, 및 이를 포함하는 사이토카인 라이브러리 |
| CA3125770A1 (en) * | 2019-01-18 | 2020-07-23 | Voyager Therapeutics, Inc. | Methods and systems for producing aav particles |
| MX2021010134A (es) * | 2019-02-22 | 2021-09-23 | Univ Pennsylvania | Virus adenoasociado recombinante para el tratamiento de la neurodegeneracion de inicio en adultos asociada a grn. |
| CA3162618A1 (en) * | 2019-03-20 | 2020-09-24 | Peter Jungsoo PARK | Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases |
| TW202111127A (zh) | 2019-07-24 | 2021-03-16 | 美商航海家醫療公司 | 用於治療亨丁頓舞蹈症之組合物及方法 |
| GB201913974D0 (en) | 2019-09-27 | 2019-11-13 | King S College London | Vector |
-
2019
- 2019-09-27 GB GB201913974A patent/GB201913974D0/en not_active Ceased
-
2020
- 2020-09-28 JP JP2022519283A patent/JP7854715B2/ja active Active
- 2020-09-28 CN CN202410972636.6A patent/CN119913208A/zh active Pending
- 2020-09-28 WO PCT/EP2020/077144 patent/WO2021058830A1/en not_active Ceased
- 2020-09-28 CA CA3155742A patent/CA3155742A1/en active Pending
- 2020-09-28 EP EP20781509.3A patent/EP4034664A1/en active Pending
- 2020-09-28 CN CN202410972634.7A patent/CN119753024A/zh active Pending
- 2020-09-28 AU AU2020354538A patent/AU2020354538A1/en active Pending
- 2020-09-28 US US17/763,644 patent/US12680109B2/en active Active
- 2020-09-28 CN CN202080067598.XA patent/CN114450413B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112020006786A2 (pt) | composições e métodos para editar rna | |
| US10494619B2 (en) | High isomerohydrolase activity mutants of human RPE65 | |
| US20230227802A1 (en) | Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency | |
| WO2016150964A1 (en) | Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia | |
| JP2024543918A (ja) | Aadc、gdnfポリヌクレオチド及びそのパーキンソン病を治療するための使用 | |
| CA3169529A1 (en) | Compositions and methods for the treatment of metabolic liver disorders | |
| CN104936606A (zh) | 糖原贮积病的基因疗法 | |
| JP2022093334A (ja) | アンチセンスオリゴヌクレオチドおよび糖原病Ia型予防または治療用組成物 | |
| KR20230123460A (ko) | Neurod1 벡터 | |
| US20240175054A1 (en) | Composition and methods for the treatment of fabry disease | |
| TW202507008A (zh) | 用於治療與葡萄糖神經醯胺酶β1缺陷相關之病症的組合物及方法 | |
| JP2023520402A5 (cg-RX-API-DMAC7.html) | ||
| CN115927412A (zh) | 密码子优化的补体因子i | |
| US20220339183A1 (en) | Treatment of tauopathies | |
| JP2025503910A5 (cg-RX-API-DMAC7.html) | ||
| JP2024505081A (ja) | 神経変性疾患を治療するための遺伝子療法 | |
| CN116670291A (zh) | 用于神经退行性疾病的基因疗法 | |
| CN116656704B (zh) | 用于治疗法布里病的转基因表达盒 | |
| WO2022187671A1 (en) | Compositions and methods for the treatment of hemophilia | |
| US20250361527A1 (en) | Vector-based gene therapy for elongator acetyltransferase complex subunit 1 (elp1) | |
| KR20250143161A (ko) | 시누클레인병증의 치료를 위한 유전자 요법 | |
| WO2024079292A1 (en) | Gene therapy treatment | |
| IL294777A (en) | gene therapy | |
| WO2022059014A1 (en) | Methods for treating alpha-synuclein-related diseases | |
| CN116710566A (zh) | Neurod1载体 |